The Swiss stock market is showing weakness in mid-day trading on Wednesday.
Following yesterday's deal to secure a Greek rescue package, there is little reason to stage a further rally after the gains posted earlier in the year.
The benchmark SMI has declined 0.79 percent to 6,188.63. The SLI is down 0.96 percent to 941.71. The SPI has retreated 0.8 percent to 5,603.54.
Nobel Biocare is one of the biggest losers among the blue chips. Shares are down 2.7 percent following the release of results from rival Straumann.
There is also weakness among the financials. UBS has declined 1.6 percent. Credit Suisse is down 1.2 percent.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org